These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 33573495)

  • 1. Efficacy and safety of a porcine peritoneum-derived matrix in diabetic foot ulcer treatment: a pilot study.
    Ai-Jalodi O; Sabo M; Patel K; Bullock N; Serena L; Breisinger K; Serena TE
    J Wound Care; 2021 Feb; 30(Sup2):S18-S23. PubMed ID: 33573495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of tissue engineering products for the management of neuropathic diabetic foot ulcers: an interim analysis.
    Frykberg RG; Cazzell SM; Arroyo-Rivera J; Tallis A; Reyzelman AM; Saba F; Warren L; Stouch BC; Gilbert TW
    J Wound Care; 2016 Jul; 25(Sup7):S18-S25. PubMed ID: 29027848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Pilot Study to Evaluate the Effects of Perfusion-decellularized Porcine Hepatic-derived Wound Matrix on Difficult-to-heal Diabetic Foot Ulcers.
    Fridman R; Engelhardt J
    Wounds; 2017 Oct; 29(10):317-323. PubMed ID: 29091040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An observational pilot study using a purified reconstituted bilayer matrix to treat non-healing diabetic foot ulcers.
    Armstrong DG; Orgill DP; Galiano RD; Glat PM; Kaufman JP; Carter MJ; Zelen CM
    Int Wound J; 2020 Aug; 17(4):966-973. PubMed ID: 32266774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pilot study evaluating non-contact low-frequency ultrasound and underlying molecular mechanism on diabetic foot ulcers.
    Yao M; Hasturk H; Kantarci A; Gu G; Garcia-Lavin S; Fabbi M; Park N; Hayashi H; Attala K; French MA; Driver VR
    Int Wound J; 2014 Dec; 11(6):586-93. PubMed ID: 23163982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of diabetic foot ulcers with dehydrated amniotic membrane allograft: a prospective case series.
    Abdo RJ
    J Wound Care; 2016 Jul; 25(Sup7):S4-S9. PubMed ID: 29027851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Prospective, Randomized, Blinded, Controlled Trial Comparing Transdermal Continuous Oxygen Delivery to Moist Wound Therapy for the Treatment of Diabetic Foot Ulcers.
    Driver VR; Reyzelman A; Kawalec J; French M
    Ostomy Wound Manage; 2017 Apr; 63(4):12-28. PubMed ID: 28448266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human placental membrane as a wound cover for chronic diabetic foot ulcers: a prospective, postmarket, CLOSURE study.
    Pacaccio DJ; Cazzell SM; Halperin GJ; Kasper MA; Neutel JM; O'Carroll BD; Reyzelman AM
    J Wound Care; 2018 Jul; 27(Sup7):S28-S37. PubMed ID: 30008251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy and safety of Grafix(®) for the treatment of chronic diabetic foot ulcers: results of a multi-centre, controlled, randomised, blinded, clinical trial.
    Lavery LA; Fulmer J; Shebetka KA; Regulski M; Vayser D; Fried D; Kashefsky H; Owings TM; Nadarajah J;
    Int Wound J; 2014 Oct; 11(5):554-60. PubMed ID: 25048468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of bacterially contaminated lower extremity ulcers with a fatty acid-containing wound matrix: a case series.
    Cole W
    J Wound Care; 2024 Aug; 33(8):554-559. PubMed ID: 39149927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Prospective, Descriptive Study to Assess the Clinical Benefits of Using Calendula officinalis Hydroglycolic Extract for the Topical Treatment of Diabetic Foot Ulcers.
    Buzzi M; de Freitas F; Winter M
    Ostomy Wound Manage; 2016 Mar; 62(3):8-24. PubMed ID: 26978856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the number of cellular and/or tissue-based product applications required to treat diabetic foot ulcers and venous leg ulcers in non-hospital outpatient department settings.
    Carpenter S; Ferguson A; Bahadur D; Estapa A; Bahm J
    Wounds; 2024 Aug; 36(8):245-254. PubMed ID: 39241764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wound closure in patients with DFU: a cost-effectiveness analysis of two cellular/tissue-derived products.
    Gilligan AM; Waycaster CR; Landsman AL
    J Wound Care; 2015 Mar; 24(3):149-56. PubMed ID: 25764960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poorly designed research does not help clarify the role of hyperbaric oxygen in the treatment of chronic diabetic foot ulcers.
    Mutluoglu M; Uzun G; Bennett M; Germonpré P; Smart D; Mathieu D
    Diving Hyperb Med; 2016 Sep; 46(3):133-134. PubMed ID: 27723012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective, randomised, controlled, multicentre clinical trial examining healing rates, safety and cost to closure of an acellular reticular allogenic human dermis versus standard of care in the treatment of chronic diabetic foot ulcers.
    Zelen CM; Orgill DP; Serena T; Galiano R; Carter MJ; DiDomenico LA; Keller J; Kaufman J; Li WW
    Int Wound J; 2017 Apr; 14(2):307-315. PubMed ID: 27073000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical oxygen therapy promotes the healing of chronic diabetic foot ulcers: a pilot study.
    Hayes PD; Alzuhir N; Curran G; Loftus IM
    J Wound Care; 2017 Nov; 26(11):652-660. PubMed ID: 29131746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of a dual-layer amniotic membrane in the treatment of diabetic foot ulcers: an observational study.
    Sledge I; Maislin D; Bernarducci D; Snyder R; Serena TE
    J Wound Care; 2020 Sep; 29(Sup9):S8-S12. PubMed ID: 32924804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicentre prospective randomised controlled comparative parallel study of dehydrated human umbilical cord (EpiCord) allograft for the treatment of diabetic foot ulcers.
    Tettelbach W; Cazzell S; Sigal F; Caporusso JM; Agnew PS; Hanft J; Dove C
    Int Wound J; 2019 Feb; 16(1):122-130. PubMed ID: 30246926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel approach for the treatment of diabetic foot ulcers using a multimodal wound matrix: a clinical study.
    Simman R; Bakewell SJ; Bell D; Shuman S; Cheney M
    J Wound Care; 2024 Oct; 33(10):772-777. PubMed ID: 39388204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-adrenergic antagonist for the healing of chronic diabetic foot ulcers: study protocol for a prospective, randomized, double-blinded, controlled and parallel-group study.
    Kaur R; Tchanque-Fossuo C; West K; Hadian Y; Gallegos A; Yoon D; Ismailyan L; Schaefer S; Dahle SE; Isseroff RR
    Trials; 2020 Jun; 21(1):496. PubMed ID: 32513257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.